MUSCAT : Under the distinguished patronage of His Excellency AbdulSalam bin Mohammed Al Murshidi, President of the Oman Investment Authority, the Insparya Hair Transplant Clinical Group, co-founded by celebrated footballer Cristiano Ronaldo, officially opened its first Middle Eastern branch at Oman International Hospital, Muscat.
This pioneering facility marks Insparya’s 13th global location and represents its initial foray into the Middle East, following successful launches across Portugal, Spain, and Italy. The inauguration was graced by the presence of esteemed guests including Sheikha Amal bint Suhail Bahwan, Chairperson of Al Afia Healthcare Development and Investment Company and Vice Chairperson of Suhail Bahwan Group Holding, alongside other dignitaries and health sector experts.
His Excellency Al Murshidi
Read More
- Oman-UAE rail link to begin trial operations in fourth quarter of 2027, Transport Minister says
- O-Green installs world’s largest onshore wind turbine outside China at Oman’s Duqm
- Young innovators at ABM lead the way in climate action at Oman Climate Week
- Bank Muscat continues to introduce employees’ children to future career opportunities in banking
- Total value of fish in Oman reaches RO 320.8 million by June 2026
highlighted the strategic selection of Oman as the inaugural Middle Eastern country for Insparya, emphasizing the Sultanate’s commitment to enhancing its healthcare sector in alignment with the Oman 2040 vision. He noted the project’s role in bolstering private investment and advancing technological integration within the health services.
Sheikha Amal
expressed her enthusiasm for the collaboration with Insparya Group, noting the substantial enhancement this brings to the Sultanate’s healthcare offerings. The new center not only elevates local health services to international standards but also augments Oman’s medical tourism sector.
Sandro Cardoso,
Global Executive Board Member of Marketing and Commerce at Insparya Group, elaborated on the Group’s ambition to redefine industry standards globally. The Insparya branch in Oman is equipped with the latest in hair transplant technology, including the BotHair UltraPlus Insparya, underscoring the Group’s commitment to innovation and quality.
Dr. Carlos Portinha
, Chief Clinical Officer of Insparya Group, detailed the group’s integration of AI and advanced biomedical and robotic research aimed at enhancing hair transplant efficacy and patient outcomes. He reaffirmed Insparya’s dedication to setting a new benchmark in hair care innovation.
Moreover, Marcelo
Pereira, CEO of Oman International Hospital, praised the facility’s role in supporting national healthcare, reducing the burden on public services, and providing world-class treatments and facilities.
Insparya Group’s expansion into the Middle East through Oman International Hospital signifies a significant milestone in global healthcare innovation, promising enhanced accessibility to premier hair transplant services for residents across the GCC and Arab nations.
